Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Check with your health care professional or doctor for additional medical advice, or if you have health questions, concerns, or for more information about this medicine
(Springer International Publishing AG, Cham, Switzerland), 195213
Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy
Quick dispatch ensures prompt delivery to domestic and international markets
When delivered using advanced technology, nutrients can achieve up to 5x more absorption compared to standard pills and powders
Moreover, active efflux transporters, such as breast cancer resistance protein (BCRP), P-glycoprotein (P-gp), and multidrug resistance-associated proteins (MRPs), expel many therapeutic agents from the endothelial cells back into the bloodstream, significantly reducing their CNS infiltration 69,70
